<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="activity_corpus\PMC7765853\results\search\activity\results.xml">
  <result pre="antiparasitic, antioxidant, anti-inflammatory, antitumor, skin disorders beneficial effects, next to" exact="antihyperglycemic" post="and anti-Alzheimer activities were reported and confirmed in multiple"/>
  <result pre="and terpenoids [20]. Luteolin-O-glucuronide and luteolin-7-O-glucoside are the main flavonoid" exact="derivatives" post="found in the hydroalcoholic extracts, decoctions, and infusions of"/>
  <result pre="in the field, OEO represents an efficient alternative as an" exact="antimicrobial agent" post="against both Gram-positive and Gram-negative bacterial strain [28,29,30]. Because"/>
  <result pre="crucial molecules and ions from the bacterial cell [29]. The" exact="disinfectant" post="and antibacterial properties of the OEO were attested for"/>
  <result pre="of the OEO and they are responsible for the plantâ€™s" exact="antimicrobial" post="properties [31]. The antibacterial activity of the OEO results"/>
  <result pre="bacteria S. aureus, E. coli, P. aeruginosa, K. pneumoniae. 4.2." exact="Antifungal" post="Activity The antifungal activity of OEO is based on"/>
  <result pre="E. coli, P. aeruginosa, K. pneumoniae. 4.2. Antifungal Activity The" exact="antifungal" post="activity of OEO is based on the presence of"/>
  <result pre="presence of a high amount of thymol and carvacrol. Their" exact="antifungal" post="action is related to the disturbance of the fungal"/>
  <result pre="with the interference of ergosterol synthesis [48]. Studies about the" exact="antifungal" post="properties of Origanum vulgare L. essential oil are shown"/>
  <result pre="vulgare L. essential oil are shown in Table 3. 4.3." exact="Antiparasitic" post="Activity Relevant studies on the antiparasitic activity of OEO"/>
  <result pre="in Table 3. 4.3. Antiparasitic Activity Relevant studies on the" exact="antiparasitic" post="activity of OEO are shown in Table 4. This"/>
  <result pre="with OEO for 16 h [56]. 4.4. Antioxidant Activity The" exact="antioxidant" post="activity of Origanum vulgare L. essential oil is attributed"/>
  <result pre="inflammatory genes due to the presence of carvacrol [65]. The" exact="anti-inflammatory" post="activities studied for Origanum vulgare L. essential oil are"/>
  <result pre="are shown in Table 6. Cheng et al. determined the" exact="anti-inflammatory" post="effect on lipopolysaccharide (LPS) murine macrophage cells (RAW264.7) after"/>
  <result pre="respectively (p &amp;gt; 0.05) [68]. Carrasco et al. studied the" exact="anti-inflammatory" post="activity of essential oils from 3 types of oregano"/>
  <result pre="resistance and also the negative side effects of traditional chemotherapeutic" exact="agents" post="[70]. The antiproliferative and cytotoxic effects of OEO have"/>
  <result pre="both an inducer of cell proliferation and a supporter of" exact="wound healing" post="by PCNA modulation [73]. Laothaweerungsawat et al. revealed the"/>
  <result pre="Kesan-Edirne, Turkey were investigated by Sarikuku et al. for their" exact="antidiabetic" post="activity. The highest Î±-glucosidase inhibitory activity was recorded for"/>
  <result pre="thus, extending the application of OEO in aqueous formulations with" exact="antimicrobial" post="activity useful in acne treatment. In this study, OEO"/>
  <result pre="nanoemulsion, because among all tested EO, it exhibited the highest" exact="antimicrobial" post="effect against acne-causing bacteria in vitro [39]. The topical"/>
  <result pre="of carvacrol, the major component of this essential oil, possessing" exact="analgesic" post="and anti-inflammatory activity [68]. Microemulsion systems containing OEO were"/>
  <result pre="the major component of this essential oil, possessing analgesic and" exact="anti-inflammatory" post="activity [68]. Microemulsion systems containing OEO were successfully obtained"/>
  <result pre="the IL-6 and TNF-Î± secretion was determined to evaluate the" exact="anti-inflammatory" post="activity of OEO containing microemulsions. According to the results"/>
  <result pre="carvacrol in the skin layer (2.6 Â± 1.3%). The OEO" exact="anti-inflammatory" post="activity was greatly improved by its incorporation in this"/>
  <result pre="rich essential oils, the major associated pharmacological effects are the" exact="antimicrobial" post="properties. This review was tailored to cover important details"/>
  <result pre="high in carvacrol and thymol represents an efficient alternative as" exact="antimicrobial agent" post="against both Gram-positive and Gram-negative bacterial strains including multiresistant"/>
  <result pre="bacteria S. aureus, E. coli, P. aeruginosa, K. pneumoniae. The" exact="antioxidant" post="activity of OEO is attributed to the presence of"/>
  <result pre="Scanning electron microscope T24 Urinary bladder carcinoma TAS The total" exact="antioxidant" post="status TEM Transmission electron microscopy TIMP-1 Tissue inhibitor of"/>
  <result pre="of Origanum vulgare L. Essential OilAMB Express201994110.1186/s13568-019-0764-y30915590 15.BahmaniM.KhaksarianM.Rafieian-kopaeiM.AbbasiN.Overview of the" exact="Therapeutic" post="Effects of Origanum vulgare and Hypericum Perforatum Based on"/>
  <result pre="Isolates of Candida Albicans and Candida GlabrataOpen Chem.20201810811810.1515/chem-2020-0011 51.HashemiM.EhsaniA.AminzareM.HassanzadazarH.Antioxidant and" exact="Antifungal" post="Activities of Essential Oils of Origanum vulgare Ssp. Gracile"/>
  <result pre="Leaves from IranJ. Food Qual. Hazards Control20163134140 52.VinciguerraV.RojasF.TedescoV.GiusianoG.AngiolellaL.Chemical Characterization and" exact="Antifungal" post="Activity of Origanum vulgare, Thymus Vulgaris Essential Oils and"/>
  <result pre="Integrity of Human Sperm DNAInt. J. Reprod. Med.202020201810.1155/2020/1230274 79.MurrayA.P.FaraoniM.B.CastroM.J.AlzaN.P.CavallaroV.Natural AChE" exact="Inhibitors" post="from Plants and Their Contribution to Alzheimerâ€™s Disease TherapyCurr."/>
  <result pre="Oils Loaded in Nanosystems: A Developing Strategy for a Successful" exact="Therapeutic" post="ApproachEvid. Based. Complement. Alternat. Med.2014201465159310.1155/2014/65159324971152 82.HosseiniS.F.ZandiM.RezaeiM.FarahmandghaviF.Two-Step Method for Encapsulation"/>
  <result pre="were mentioned above in reference [34]. [34] ijms-21-09653-t003_Table 3Table 3" exact="Antifungal" post="activity of Origanum vulgare L. essential oil (OEO). Fungal"/>
  <result pre="of the oral cavity in HIV-positive patients. The in vitro" exact="antifungal" post="effectiveness was performed using microdilution and disc diffusion methods.According"/>
  <result pre="chemical constituents were mentioned above in [33].Standards for comparison in" exact="antifungal" post="tests were Nystatin BP, 100 Î¼g/mL, with CZD ="/>
  <result pre="with CZD = 34 mm (Trichophyton rubrum)Standards for comparison in" exact="antifungal" post="tests were Nystatin BP, 100 Î¼g/mL, with CZD ="/>
  <result pre="constituents were mentioned above in reference [33].Standards for comparison in" exact="antifungal" post="tests were Nystatin BP, 100 Î¼g/mL, with CZD ="/>
  <result pre="were mentioned above in reference [38]. [38] ijms-21-09653-t004_Table 4Table 4" exact="Antiparasitic" post="activity of Origanum vulgare L. essential oil (OEO). Parasite"/>
  <result pre="the concentration of 2 Ã— 10âˆ’3% the TAS (the total" exact="antioxidant" post="status) (2.20 Â± 0.16 mmol/g) values increased by 307.4%"/>
  <result pre="UK)The protein concentrations were determined using the Bradford method.The total" exact="antioxidant" post="status (TAS) levels of the OEO (8 Ã— 10âˆ’3,"/>
  <result pre="500 mg/mL. human breast adenocarcinoma (MCF-7)human colon adenocarcinoma (HT-29) The" exact="cytotoxicity" post="test was performed by sulforhodamine B assay.Cancer cells were"/>
  <result pre="800 Âµg/ÂµL. hepatocarcinoma cell line (HepG2)non-tumour cell line (HEK293) The" exact="cytotoxicity" post="test was performed by MTT assay.They also analysed the"/>
  <result pre="for 3 days. Mice treated with nanoemulsion presented a higher" exact="anti-inflammatory" post="response (&amp;gt;60%) compared to the positive control erythromycin (20%)The"/>
  <result pre="(&amp;gt;60%) compared to the positive control erythromycin (20%)The in vivo" exact="antimicrobial" post="activity of OEO nanoemulsion was assessed where bacterialcounts of"/>
  <result pre="tissue with the absence of inflammatory reaction. [39] Wound and" exact="anti-inflammatory" post="potential OEO was provided by Esperis S.p.A., Milan, Italy.The"/>
  <result pre="0.00041%, v/v) were measured using a sulforhodamine B assayThe potential" exact="anti-inflammatory" post="and tissue remodelling properties of the OEO were tested"/>
 </snippets>
</snippetsTree>
